APA (7th ed.) Citation

Bai, Y., Xu, J., Li, D., Zhang, X., Chen, D., Xie, F., . . . Zhang, Y. (2023). HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma. Clinical Epigenetics, 15(1), 1. https://doi.org/10.1186/s13148-023-01508-7

Chicago Style (17th ed.) Citation

Bai, Yi, et al. "HepaClear, a Blood-based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-stage Hepatocellular Carcinoma." Clinical Epigenetics 15, no. 1 (2023): 1. https://doi.org/10.1186/s13148-023-01508-7.

MLA (9th ed.) Citation

Bai, Yi, et al. "HepaClear, a Blood-based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-stage Hepatocellular Carcinoma." Clinical Epigenetics, vol. 15, no. 1, 2023, p. 1, https://doi.org/10.1186/s13148-023-01508-7.